Role of IL-4 in delayed type hypersensitivity

Clinical and Experimental Immunology

Volumn 103, Issue 1, 1996, Pages 1-4

  Asherson, G L ^a,b   Dieli, F ^a   Sireci, G ^a   Salerno, A ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Delayed hypersensitivity; IL 4 contact sensitivity; Picryl; T cells

Indexed keywords

INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; CELL LINE; CONTACT SENSITIVITY; DELAYED HYPERSENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0030049428     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.845537.x     Document Type: Review

References (46)

1. +). J Invest Dermatol 1994; 102:321-7.
2. Turk JL. Delayed hypersensitivity, 2nd edn. Amsterdam: North-Holland, 1980.
3. Miller JFAP, Vadas MA, Whitelaw A, Gamble J. A radioisotopic method to measure delayed type hypersensitivity in the mouse. Int Arch Allergy Appl Immunol 1975; 49:693-708.
4. Enk AH, Angeloni VL, Udey MC et al. An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in skin. J Immunol 1993; 150:3698-704.
5. Ptak W, Geba GP, Askenase PW. Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody: mediation by serolonin and inhibition by histamine. J Immunol 1991; 146:3629-36.
6. Meade R, Van Loveren H, Parmentier H et al. The antigen-binding T cell factor or PCI-F sensitizes mast cells for in vitro release of serotonin: comparison with monoclonal IgE antibody. J Immunol 1986; 141:2704-13.
7. Galli SJ. New concepts about the mast cell. New Eng J Med 1993; 328:257-65.
8. Smith TJ, Ducharmes IA, Weis JH. Preferential expression of IL-12 or IL-4 by murine bone marrow mast cells derived in mast cell growth factor or IL 3. Eur J Immunol 1994; 24:822-6.
9. Cher DJ, Mosmann TR. Two types of murine helper T clones. II. Delayed-type hypersensitivity his mediated by TH1 clones. J Immunol 1987; 138:3688-94.
10. Fong TAT, Mosmann TR. The role of IFN-γ in delayed-type hypersensitivity (DTH) mediated by TH1 clones. J Immunol 1989; 143:2887-94.
11. Bianchi ATJ, Hooikjkaas H, Benner R et al. Clones of helper T cells mediate antigen-specific. H-2-restricted DTH. Nature 1981; 290:62-65.
12. Thomas WR, Mottram PL, Miller JFAP. Hapten-specific T cell lines mediating delayed hypersensitivity to contact-sensitizing agents. J Exp Med 1982; 156:300-5.
13. Gross A, Frankemburg S. Induction of macrophage mobility by a T cell line from BALB/c mice specific for Plasmodium berghei. J Parasitol 1988; 74:379-85.
14. + T lymphocytes with protective and chemotactic activities in vitro. Infect Immun 1991; 59:4531-7.
15. Dieli F, Asherson GL, Colonna Romano G et al. IL-4 is essential for systemic transfer of delayed hypersensitivity by T cell lines. Role of γδ cells. J Immunol 1994; 152:2698-704,
16. Salerno A, Dieli F, Sireci G et al. Interleukin-4 is a critical mediator in contact sensitivity. Immunology 1995; 84:404-9.
17. Piguet PF, Grau GE, Hauser C et al. TNF is a critical mediator in hapten induced irritant and contact hypersensitivity response. J Exp Med 1991; 173:673-9.
18. Asherson GL, Zembala M. The anatomical location of cells which mediate contact sensitivity in the lymph nodes and bone marrow. Nature New Biol 1973; 244:176-9.
19. Mohler KM, Butler LD. Differential production of IL-2 and IL-4 mRNA in vivo after primary sensitization. J Immunol 1990; 145:1734-9.
20. Marcinkiewicz J, Chain BM. Regulation of in vitro release of TH2 type cytokines (IL-4, IL-6) in the T cell response to the trinitrophenyl (TNP) hapten. Cell Immunol 1993; 149:406-18.
21. Thomson JA, Troutt AB, Kelso A. Contact sensitization to oxazolone: involvement of both interferon-gamma and interleukin-4 in oxazolone-spccific Ig and T-cell responses. Immunology 1994; 78:185-92.
22. Dieli F, Asherson GL, Bonanno CT et al. Major histocompatibility control of the class of the immune response to the hapten trinitrophenyl. Immunology 1995; 84:355-9.
23. Ptak W, Askenase PW. γδ cells assist αβ T cells in adoptive transfer of contact sensitivity. J Immunol 1992; 149:3503-8.
24. Hiromatsu K, Yoshikai Y, Matsuzaki G et al. A protective role of γ/δ T cells in primary infection with Listeria monocytogenes in mice. J Exp Med 1992; 175:49-56.
25. Emoto M, Danbara H, Yoshikai Y. Induction of γ/δ T cells in murine salmonellosis by an avirulent but not by a virulent strain of Salmonella choleraesuis. J Exp Med 1992; 176:363-9.
26. Inonue T, Yoshikai Y, Matsuzaki G et al. Early appearing γ/δ-bearing T cells during infection with Calmette Guerin bacillus. J Immunol 1991; 146:2754-9,
27. Modlin R, Pirmez C, Hofman FM et al. Lymphocytes bearing antigen specific γδ T cell receptors accumulate in human infectious disease lesions. Nature 1989; 339:544-6.
28. Peterman GM, Spencer C, Sperling AI et al. Role of ~γδ T cells in murine collagen-induced arthritis. J Immunol 1993; 151:6546-58.
29. Kjeldsen-Dragh J, Quayle A, Kalvenes C et al. T γδ cells in juvenile rheumatoid arthritis and rheumatoid arthritis. Scand J Immunol 1990; 32:503-9.
30. Thornhill MH, Wellicome SM, Mahiouz DL et al. Tumor necrosis factor combines with IL-4 or IFN-γ to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent mechanisms. J Immunol 1991; 146:592-8.
31. Masinovsky B, Urdal D, Gallatin MJ. IL-4 acts synergistically with IL-1β to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1. J Immunol 1990; 145:2886-95.
32. Luscinskas FW, Kansas GS, Ding H et al. Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, β1-integrins and β2-integrins. J Cell Biol 1994; 125:1417-27.
33. Chisholm PL, Williams CA, Lobb RR. Monoclonal antibodies to the integrin α4 subunit inhibit the murine contact hypersensitivity response. Eur J Immunol 1993; 23:682-8.
34. + T lymphocyte binding to fibronectin and immune-cell accumulation in inflammatory sites by non-peptidic mimetics of Arg-Gly Asp. Clin Exp Immunol 1994; 95:270-6.
35. Elfaki MG, O'Sullivan NL, Skanders CA et al. Inhibition of lymphocyte adherence to rat lacrimal acinar epithelium by interleukin-4 and transforming growth factor-beta. Cell Immunol 1994; 153:154-62.
36. Allen JB, Wong HL, Costa GL et al. Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis. J Immunol 1993; 151:4344-51.
37. Mulligan MS, Jones ML, Vaporciyan AA et al. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol 1993; 151:5666-74.
38. Rapoport MJ, Jaramillo A, Zipris D et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1993; 178:87-99.
39. Muller KM, Jaunin F, Masouye I et al. Th2 cells mediate IL-4 dependent local tissue inflammation. J Immunol 1994; 152:2698-704.
40. Chensue SW, Warmington KS, Ruth J et al. Cross-regulatory role of interferon-gamma (IFN-γ), IL-4 and IL-10 in schistosome egg granuloma formation: in vivo regulation of Th activity and inflammation. Clin Exp Immunol 1994; 98:395-400.
41. Rollins PJ, Pober JS. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. Am J Pathol 1991; 138:1315-9.
42. Horohov DW, Crim JA, Smith PL et al. IL-4 (B-cell-stimulatory factor 1) regulates multiple aspects of influenza virus-specific cell-mediated immunity. J Immunol 1988; 141:4217-23.
43. Fanslow WC, Clifford KN, Park LS et al. Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor. J Immunol 1991; 147:535-40.
44. Powrie F, Menon S, Coffman RL. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 1993; 23:3043-9.
45. Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute vs. chronic atopic dermatitis. J Clin Invest 1994; 94:870-6.
46. Kirk AD, Ibrahim S, Dawson DV et al. Characterisation of cells expressing the γδ antigen receptor in human renal allografts. Human Immunol 1993; 36:11-19.